OSAKA, Japan, and SAN DIEGO, Calif., Sept. 8, 2006 — Panasonic Factory Solutions Co. Ltd. and Kalypsys Inc. announced today the establishment of a broad collaboration for the development of next-generation drug discovery systems.

The collaboration covers a wide range of activities, including the development, production and marketing of equipment and integrated systems that will enable research institutions and pharmaceutical companies to address all aspects of drug discovery and life science research. Panasonic will lend its expertise in product manufacturing, engineering solutions and innovative marketing. Kalypsys will contribute its experience in developing systems used today by the world's top research institutions and pharmaceutical companies in the United States.

Katsutoshi Kanzaki, president of Panasonic Factory Solutions Co. Ltd., stated: "Through this collaboration, we expect a great synergy in the development of drug discovery systems. The combination of our automation technology and Kalypsys' drug discovery technology will enable us to meet the demands of research institutions and pharmaceutical companies that need a more versatile suite of drug discovery systems."

John McKearn, Ph.D., president and chief executive officer of Kalypsys, added: "The Panasonic/Kalypsys collaboration will set the stage for the delivery of the next generation of drug discovery technology. From our perspective at Kalypsys, it's another validation of the high caliber product we provide to our clients as well as use internally to drive our own drug discovery program. Moreover, Panasonic will enable us to expand our global reach."

About Panasonic Factory Solutions

Panasonic Factory Solutions Co. Ltd. (PFSC) is a domain company within Matsushita Electric Industrial. PFSC is the largest electronics manufacturer in the world and manages a global network of business units based in Asia, Europe and North America. Known globally for surface mount technology and micro-electronics backend packaging, PFSC is now extending its capabilities into the life science industry. Leveraging the high-precision positioning, image processing and dispensing technologies cultivated in the factory solutions business, PFSC is now focusing its efforts on the new business of High Throughput Screening systems for drug discovery. Improved automation and tact systems will enhance processes to discover new drugs.

For more information, call 847.495.6109 or visit or

Company Profile
  • Headquarters: 2-7 Matsuba-cho, Kadoma City, Osaka 571-8502, Japan
  • Established: 2003
  • Representative: Katsutoshi Kanzaki, President
  • Number of employees: 3,150

About Kalypsys

Kalypsys is a San Diego-based pharmaceutical company that is changing the way drugs are discovered and developed. Unmatched from idea to clinical proof, Kalypsys seamlessly integrates its scientific expertise and technologies to develop small molecule drugs in a fast, efficient and effective manner. The company's discovery and clinical pipeline consists of drugs that target inflammation, oncology and cardiovascular/metabolic diseases. In addition to focusing on its own products, Kalypsys partners with top-tier pharmaceutical companies to rapidly advance the identification, development and commercialization of new therapeutics.

For more information, call 858.754.3300 or visit

Company Profile
  • Headquarters: 10420 Wateridge Circle, San Diego, CA 92121
  • Established: 2001
  • Representative: John McKearn, Ph.D., President & Chief Executive Officer
  • Number of employees: 115